Bindu Potugari M.D.,?
Update this Profile
Bindu Potugari M.D.,, Oncologist
We verify the medical license of each FindaTopDoc Verified Doctor to ensure that their license is active and they are in good medical standing.

Bindu Potugari M.D.,

Oncologist | Medical Oncology

2800 W GRAND BLVD FL 3 DETROIT MI, 48202

About

Dr. Bindu Potugari is an oncologist practicing in DETROIT, MI. Dr. Potugari specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Potugari manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.

Provider Details

FemaleEnglish

Bindu Potugari M.D.,'s Practice location

2800 W GRAND BLVD FL 3 -
DETROIT, MI 48202
Get Direction
New patients: 313-556-8820
Fax: 313-916-4989

Bindu Potugari M.D.,'s reviews

(0)
Write Review

Recommended Articles

  • What is Testicular Cancer: Get the Facts

    Testicular cancer is a malignancy that affects the testes, which are the sex glands in men that are responsible for secreting the male sex hormone testosterone and for producing sperm cells that fertilize female eggs to kick start a pregnancy.Prevalence of testicular cancerIn the United States,...

  • New Research Targets Stage Zero Breast Cancer

    A new breast cancer diagnosis may provoke many questions. As baby boomers age, the possibility of cancer increases. Gen Xers and millennial's may also wonder about their risks, especially if breast cancer runs in the family.Receiving a diagnosis of “stage zero” breast cancer may be baffling....

  • Double Whammy Breast Cancer Treatment Reduces Toxicity

    A potential new therapeutic target has been identified to treat some cancer types, all the while avoiding harm to healthy cells and reducing side effects. The study, published in the journal Nature Communications, was led by a Scripps Research research team in California. It showed how a protein...

  • Ovarian Cancer Vaccine Development: An Update

    OncBioMune Pharmaceuticals, a clinical-stage bio-pharmaceutical company, is advancing its developments in vaccine technology to help boost the immune system to target cancer cells without causing harm to the patient. They have worked on prostate cancer vaccines and are working on ovarian cancer...

  • How #Cancerland Changed New York Fashion Week

    New York Fashion Week is a prestigious event that is held every year in the months of February and September. It shows off the latest fashion collections from renown designers, exhibited by the world’s most successful models. This year, AnoOno came together with #Cancerland, a U.S. non-profit...

  • Risk-Reduction Mastectomy for those with Ovarian Cancer

    A risk-reducing mastectomy is a type of surgical procedure that involves the removal of a woman’s breasts when there is an increased risk of developing breast cancer, yet there is no sign of breast cancer. Any woman who has had breast cancer is considered at high-risk of developing breast cancer...

Nearby Providers